We have previously identified a point mutation (IVS4: T→C) in the branchpoint consensus sequence of intron 4 of the lecithin:cholesterol acyltransferase (LCAT) gene in patients with fish-eye disease. To investigate the possible mechanisms responsible for the defective splicing, we made a series of mutations in the branchpoint sequence and expressed these mutants in HEK-293 cells followed by the analysis of pre-mRNA splicing using RT-PCR as well as LCAT activity assay. The results reveal that (1) the mutation of the branchpoint adenosine to any other nucleotide completely abolishes splicing; (2) the insertion of a normal branch site into the intronic sequence of the natural (IVS4-22c) or the branchpoint (IVS4-20t) mutant completely restores splicing; (3) the natural mutation can be partially rescued by making a single nucleotide change (G→A) within the branchpoint consensus sequence; and (4) other single-base changes, particularly around the branchpoint adenosine residue, significantly decrease the efficiency of splicing and thus enzyme activity. Surprisingly, the nucleotide transversion at the last position of the branchpoint sequence (i.e., IVS4-25a or 25g) result in 2.7-fold increase in splicing efficiency. Therefore, these observations clearly establish the functional significance of the branchpoint sequence of intron 4 for the splicing of the human LCAT mRNA precursors.
INTRODUCTION
The removal of introns from pre-mRNA involves the recognition of the 5'splice site, the branchpoint sequence, and 3' splice site by five small nuclear ribonucleoprotein particles (U1, U2, U5, and U4/U6 snRNPs) and a large number of non-snRNP splicing factors (1, 2, 3, 4) . The functional significance of the splice sites has been well established by the studies of a number of naturally occurring mutations and of site-directed mutagenesis at these exon/intron junctions (5, 6, 7, 8) . It is estimated that up to 15% of all point mutations causing human genetic disease result from mRNA splicing defects, most of which involve a single nucleotide substitution at the splice sites (5) . To date, only a few mutations in the branchpoint consensus sequence of introns have been reported to cause human genetic diseases (9, 10, 11, 12, 13) . However, the growing evidence indicates that the branchpoint sequence can be of essential importance for accurate and efficient splicing of human nuclear pre-mRNA.
A series of elegant genetic experiments in both yeast and mammalian cell lines have shown that base pairs exist between the branchpoint sequence and a conserved region (5'-AUGAUG-3') in U2 snRNA. (14, 15, 16) .
The branchpoint sequence is absolutely conserved in yeast the specific binding of U2AF to the polypyrimidine tract has been shown to promote the base pairing of U2 snRNA with the branchpoint sequence (21) . However, much less is still known about the mechanism of the selection of the branchpoint adenosine, which is usually located 18-40 nucleotides upstream of the 3' splice site, in the mammalian intron with respect to the base pairs between the U2 snRNA and the pre-mRNA.
The human LCAT is encoded by a single gene that is located on chromosome 16 and composed of 6 exons (22, 23) . Mutations in the LCAT gene have been demonstrated to underlie either familial LCAT deficiency or fish-eye disease (FED) (24) . We have previously identified a point mutation in intron 4 of the LCAT gene in patients with fish-eye disease (25) . This point mutation resides in a 100% matched branchpoint consensus sequence (CCCTGAC versus YNYTRAY) and it has been shown to result in the complete intron retention. Similar results have been observed when two other novel mutations (i.e., T→G or T→A) were introduced into the same site of the natural mutation (IVS4:T→C), suggesting that the highly conserved thymidine residue in the branchpoint sequence is essential for the LCAT pre-mRNA splicing (26) . LCAT gene has an unusually high conserved sequence (27) . The intron 4 of LCAT gene contains only 83 base pairs and the possible absence of cryptic branchpoint sequences in this short intron may render it highly sensitive to any alteration within the branchpoint region.
Therefore, the branchpoint sequence in intron 4 of the LCAT gene may act as a model to identify the functional significance of conserved nucleotides contained within the branchpoint sequence of the human genes.
In this study, we demonstrate that the mutations of the branchpoint adenosine residue in intron Culture medium was collected for the LCAT activity assays, and total cytoplasmic RNA was prepared using RNeasy Mini Kit (Qiagen) according to the manufacturer's protocol.
Measurement of LCAT Activity -LCAT activity in the collected media was determined using proteoliposome substrate as described previously (26 agarose gel, and the bands were visualized by ethidium bromide staining. and IVS4-23a (Fig.6A , column 6 and 7) also had a markedly decreased LCAT activities compared with that of the wild type. However, the C→ A transversion or C →T transition at the sixth position (IVS4-24a or IVS4-24t) of the consensus sequence had only a mild decreased enzyme activity (Fig.6A , column 9 and 10) as compared to wild type control. Interestingly, in contrast to these downstream mutations, the change at the last position of the branchpoint sequence, i.e., IVS4-25a or -25g, resulted in approximately 2.7-fold increase in LCAT activity compared with the intron 4 wild type (Fig.6A, column 11 and 12 ).
RESULTS

Generation of Mutations in the Branchpoint
The effects of these intron mutations on the efficiency of RNA splicing were further determined by RT-PCR. As expected, the normally spliced RNA could be detected in all of these by guest on June 29, 2017
http://www.jbc.org/ Downloaded from mutants, but the efficiency of the splicing was completely different from one another. The mutant IVS4-19g and IVS4-21c had the least spliced RNAs (Fig.6B , lane 6 and 7) followed by IVS4-19a and IVS4-21t (Fig.6B, lane 5 and 8 ). The densities of the spliced RNAs for the mutants IVS-23a and 23g were less than that of wild type (Fig.5B, lane 9 and 10) , and the levels of spliced RNA in IVS4-24a and 24t were similar to those of wild type control (Fig.5B, lane 11 and 12). It was interesting to note that the RNA splicing of mutants IVS-25a and -25g was much more efficient than that of the wild type (Fig.5B, lane 13 and 14) , approximately 50% of the transcripts were spliced. All of these observations are consistent with the corresponding LCAT activities for these mutants. Therefore, it appears that the efficiency of splicing is well correlated with the activity of LCAT secreted from the transfected HEK-293 cells into the medium.
Another surprising observation in this study was that the exchange of the wild type branchpoint sequence of intron 4 with the invariant TACTAAC box of yeast did not increase the efficiency of splicing but had a mildly decreased spliced RNA (Fig.6B , lane 4) and LCAT activity (Fig.5A ).
DISCUSSION
We have previously shown that a point mutation in a lariat branchpoint sequence of intron 4 of the LCAT gene (IVS4:T-22C) resulted in the intron retention causing a human inherited disorder, fish-eye disease (25) . We have also demonstrated that the thymine residue at the fourth position of the branchpoint sequence in which the natural mutation occurs is crucial for the premRNA splicing (26) . In this report, we extend our studies into the whole region of the branchpoint sequence and further demonstrate that the branchpoint sequence of intron 4, especially the branchpoint adenosine residue and the nucleotides around it, is essential for the efficient splicing of LCAT pre-mRNA.
Previous studies have shown that the branchpoint sequence is not essential for splicing of mammalian introns since deletion or mutation of the branchpoint sequence does not abolish splicing both in vitro and in vivo (18, 19, 20) . This paradox has been explained by the utilization signal, the failure to detect any LCAT activity and the truncated protein (data not shown) in the culture medium indicates that the translation products are likely rapidly degraded within the cells (26) . Recently, another example of the branchpoint mutation that disrupt mRNA splicing in intron 9 of the low density lipoprotein (LDL) receptor has been described in a patient with familial hypercholesterolaemia (FH). This mutation disrupts the branchpoint consensus sequence and also causes intron retention (10). These observations, therefore, suggest that the branchpoint sequence plays an important role in the selection of the branchpoint nucleotide although it is poorly conserved in mammals.
In order to investigate the possible mechanisms for the defective splicing, we first inserted a normal branchpoint sequence CCCTGAC into the natural and the branchpoint mutants (IVS4-22c and IVS4-20t, respectively) 6 nucleotides upstream of the mutated branch sites (Fig.3) . The purpose of the insertion is to see whether this sequence could rescue the natural or the branchpoint mutation. As expected, we observed not only the complete restoration of the LCAT activities of both the mutants but also an increase in splicing efficiency of the branchpoint mutant compared with the intron 4 wild type construct. These results suggest that the sequence of intron 4 itself does not contain any potential cryptic branch sites. Once the branchpoint sequence had been mutated there was no alternative to back up the splicing machinery so that the consequence of the natural and the branchpoint mutations was retention of the intron. At the moment, we do not know the reasons why the introduction of the normal branch site into the intronic sequence of the branchpoint mutant increased the efficiency of LCAT pre-mRNA splicing. It is possible that two potential branch sites within a single intron might compete with each other (33). For the intron wild type and the natural mutant, either of the two potential branchpoint sequences could be screened as the branch site signal, but the one that mostly matches the consensus sequence would be preferentially utilized. In the case of the branchpoint mutant, the inserted branch site becomes the only branchpoint sequence to be used in the pre-mRNA splicing, which may be one of the possible explanations for the increased efficiency of pre-mRNA splicing.
The base-pairing interaction between the branchpoint sequence and the sequence AUGAUG in U2 snRNA is one of the early essential events in pre-mRNA splicing (14, 15, 16) . In an attempt to test the hypothesis that the natural mutation causes intron retention as the result of interference with the binding of U2 snRNA to the branchpoint sequence (Fig.5A) , we changed the naturally mutated branchpoint sequence from CCCCGAC to CCCCAAC. This alteration would produce a stronger Waston-Crick base-pair between the branchpoint region and the AUGAUG sequence in U2 snRNA compared to the natural mutation (Fig.5A ), which might, at least in part, suppress the effect of the natural mutation on the LCAT pre-mRNA splicing by increasing the ability to tolerate a mismatch at the adjacent position. As expected, the base change just one nucleotide upstream of the branchpoint adenosine residue did recover some of the LCAT activity in the medium and produce a clearly spliced RNA band although these changes were relatively small compared with the wild type control (Fig.5B and 5C ). The results reported here indicate that the strength of the base pairs between the pre-mRNA and U2 snRNA may be one of the critical factors in determining the efficiency of nuclear pre-mRNA splicing. However, this polymorphism has been observed to have no effect either on splicing in vitro or on plasma lipid concentrations in the population. This is not surprising because the last position of the consensus sequence for the mammalian branchpoint sequence could be either C or T.
Another unexpected observation made in this study is that the substitution of the normal branchpoint sequence CCCUGAC with the yeast branch site UACUAAC sequence did not increase the efficiency of LCAT pre-mRNA splicing but was modestly decreased. This result is surprising because it conflicts with a previous study (33) in which the data have shown that the optimal branchpoint sequence is the yeast UACUAAC sequence for mammalian introns.
Although the UACUAAC has perfect complementarity with the sequence AUGAUG in U2 snRNA, our results of the transfection experiments seem to not support the concept that the perfect match improves the efficiency of pre-mRNA splicing in vivo, but these are consistent with the results that the mutations of the last position of the branchpoint sequence markedly increase the splicing efficiency even though the changes reduce the match within the consensus sequence. This would, at least in part, explain why splicing is less dependent on base pairing of the pre-mRNA with U2 snRNA in mammals. For the mammalian introns, it is likely that other protein-RNA and RNA-RNA interactions are required to maintain the pre-mRNA and the U2 snRNA in the correct conformation in the absence of one or two of these base pairs.
In conclusion, by taking advantage of our in vivo assay for measuring the splicing efficiency,
we are able to demonstrate that the branchpoint consensus sequence of intron 4 is essential for the splicing of LCAT pre-mRNA. With the increasing intron sequence data available, more and more intron mutations far from the splice sites will be found to be the underlying causes for the human genetic disorders. The introduced mutations at the corresponding positions relative to the 3' splice site of LCAT intron 4 are in bold face and the 7 bp consensus sequences are underlined. 
